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The COVID-19 pandemic has caused unprecedented crisis across the world, with many
countries struggling with the pandemic. In order to understand how each country is
impacted by the virus and assess the risk on a global scale we present a regression
based analysis using two pre-existing indexes, namely the Inform and Infectious Disease
Vulnerability Index, in conjunction with the number of elderly living in the population.
Further we introduce a temporal layer in our modeling by incorporating the stringency
level employed by each country over a period of 6 time intervals. Our results show that the
indexes and level of stringency are not ideally suited for explaining variation in COVID-19
risk, however the ratio of elderly in the population is a stand out indicator in terms of
its predictive power for mortality risk. In conclusion, we discuss how such modeling
approaches can assist public health policy.
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1. INTRODUCTION
At the end of 2019, a new respiratory tract infection emerged in Wuhan, China. Termed
COVID-19, the virus has spread all over the globe, with the World Health Organization (WHO)
designating it a pandemic. Highly contagious, the disease has severely impacted economies and
elderly populations. Data scientists, epidemiologists and mathematicians are aiming to understand
and project the spread of the virus or assess the risk in each country; specifically the risk of deaths
is of deep and grave concern. It is widely established that a range of factors prevail, upon which
the COVID-19 risk or vulnerability of an individual country depends (1, 2); extending from risk
assessment of other viruses and pandemics (3). Therefore, amongst the large volume of work
on the impact of COVID-19, a stream of research attempts to decipher the various baseline or
constituent factors that could put a nation at risk to COVID-19 (4). These include the study of
socio-demographic or economic factors as well as natural elements, such as climate or temperature
(5). Typically, such factors are baseline in the sense that they cannot be altered or varied overnight.
However, they can pre-empt contingency plans and action points for agencies and organizations
enabling countries to be better prepared in response to the virus (6). A region or country at
assumed high risk could take timely actions to prepare for and preempt the spread. Prior work
has also in relation focused on how different countries compare on their level of risk (7). The wide
variety of such indicators ultimately illustrates that selection of appropriate indicators requires clear
justification. In prior work, we have also seen the usage of standardized risk indexes developed by
large organizations. These indexes are an aggregate of many indicators and factors (8). Such indexes
may also play an important role in the evaluation of COVID-19 risk. However, these indexes were
in general derived before COVID-19 by considering other viruses and as such their charting of
COVID-19 as a pandemic is not immediately clear or established. Onemay question if these indexes
can be readily used to assess COVID-19 risk given that it is acknowledged that COVID-19 is
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much more contagious than originally thought in comparison
to other corona viruses (9). Further, computing the risk of
COVID-19 is largely complicated (10)—leading to some efforts
to deduce a customized index (11).
In parallel, we also have research focusing on the impact
of factors which are more fluid and variable in nature and
depend on government intervention and policy (12). These
include social distancing measures, travel bans, lockdowns,
economic shutdown and much more (13). These can in
theory be implemented overnight and in conjunction with the
baseline variables provide an effective response strategy. Timely
interventions are hence what most government agencies aspire
to. Evaluating their effectiveness should also be an integral
component of risk modeling (14). Temporal evaluations at
key checkpoints are essential to the successful implementation
of a response plan keeping in mind non-pharmaceutical
interventions, so that scalable strategies can be employed.
While some of the prior work aims to project the efficiency
of future actions or predict the spread (15, 16), our research has
attempted to evaluate the current or present situation in terms
of identifying the mortality risk of COVID-19 on a global scale
using a wide range of predictors or indicators. Most of the prior
work attempts to assess the risk situation on a local scale (17).
The aim of any intervention or introduction of a stringency level
is to reduce the overall risk. Further, there should be regular
and timely determinations to deduce if the interventions are
contributing to a lowering of risk. Therefore, in this current
paper, we present our analysis on modeling the current and
temporal change in COVID-19 risk on a global scale through
the incorporation and comparison of not only available and
standardized risk indexes but also a temporal factor in terms of
the prevailing stringency level. As mentioned prior, these risk
indexes do not allow us to reassess the risk when the condition
of a country changes (such as when government interventions or
lockdowns are activated or softened). Nevertheless, a number of
such pre-made indexes are available and it would be worthwhile
to compare them in terms of their ability to explain the risk
of COVID-19. Therefore, in our research, we compare two
standardized indexes in terms of their efficacy to assess the risk
and vulnerability of each country toward COVID-19 and also
introduce an additional factor in terms of the stringency level
of each country.We believe our analysis is a contribution to
literature as previous temporal risk assessments for COVID-19
are for specific countries, such as China (18) or South Africa (19).
2. METHOD
Our aim was to discern the risk of COVID-19 on a global
yet temporal scale.In order to compute the risk, we wanted
to benchmark each country against its prevailing conditions
and disease vulnerability as measured by various indicators
and predictors.
2.1. Index Selection
In Gilbert et al. (8), a range of indexes and their applicability to
assess COVID-19 risk are discussed. Two indicators namely the
Inform global risk index (20) and the Infectious Disease index
(21) were deemed relevant due to their ability to “account” for not
only demographic, socio-economic, environmental and political
factors but also transmission risk, infrastructure, vulnerability
and coping capacity. Hence, we selected the indicators comprised
as part of the two indexes as the primary factors of our risk
assessment, given that they nicely complimented each other.
Their constituent indicators are summarized in a bullet list
below. We also recorded the overall value or composite score
of the indexes themselves. Data related to these indexes was
obtained from their available official documentation (20, 21);
including both the constituent indicators and the composite
index score. For the Inform global risk index the composite
score was available in the official documentation as “Enhanced
Inform 2019.” For the Infectious Disease Vulnerability index, the
composite score was available in the official documentation as
“Overall Score Normed.”
Each of the indicators were normalized on a range of 0–1. We
did however notice, that there was no mention of the ratio of
elderly population amongst the list of indicators. Proportion of
children was included and this may have been due to the focus of
the indexes on prior epidemics which were different in their risk
demographic. Therefore, we also included an additional static
indicator which illustrated the ratio of elderly in the population
(above 65 years old), as provided from World Bank. This index










9. Lack of Coping Capacity.
• Infectious Disease Vulnerability Index
1. Demographic Domain
2. Health Care Domain






Each country’s response to the emerging threat of COVID-
19 has been fluid, dynamic and unique. There is no one size
fits all approach. Therefore, representation of the prevailing
stringency is important to model in any risk assessment. With
the application of stringent measures the risk of future spread
should reduce. In order to capture a temporal assessment of
variation of risk we utilized the stringency index proposed
as the Oxford COVID-19 Government Response Tracker
(OxCGRT) (22). This is defined as “a policy stringency index
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(calculated) by combining 13 policy indicators, including school
and workplace closures, travel bans, as well as fiscal policy
measures.” To allow for the measures to take effect, and to
give increased importance for measures taken earlier rather
than later, in our modeling we considered a weighted average
stringency level for any day based on a formula provided in
literature (4).
2.3. Modeling
Our model considered COVID-19 and stringency data between
22-01-20 and 11-05-20 on 2 weeks intervals, namely (02-03-
20, 16-03-20, 30-03-20, 13-04-20, 27-04-20, and 11-05-20), such
that the model was run for each date in this list for a temporal
risk assessment across all countries data (N = 156). The data
associated with the virus was extracted from the John Hopkins
Repository (23). The number of confirmed cases and mortality
were normalized per capita based on the population, per one
million people and not on the basis of confirmed cases; due to
the inaccuracies and irregularities in testing (24).
We ran eight multiple regression models for each of the six
dates mentioned. We had two dependent variables: normalized
confirmed cases and normalized mortality. Each dependent
variable wasmodeled four times by using the two sets of indicator
independent variables in both split and composite form. The
four sets of independent variables were the indicators in the
Inform Index (9 in total) and those in the Infectious Disease
Vulnerability Index (7 in total) as well each of the indexes
in their composite form (a single score each). There was no
intermixing of indexes as independent variables across each
other or in their split or composite form. All regression models
further included A65abp (ratio of elderly in the population) and
weighted stringency level on that particular date as additional
independent variables. The list of 8 regression model types is
summarized below.
For each date in our window of six identified dates
1. DV = normalized confirmed cases; lm (IV = 9 constituent
factors of the Inform Index, A65abp, stringency level)
2. DV = normalized confirmed cases; lm (Enhanced Inform
2019, A65abp, stringency level)
3. DV = normalized mortality; lm (IV = 9 constituent factors of
the Inform Index, A65abp, stringency level)
4. DV = normalized mortality; lm (Enhanced Inform 2019,
A65abp, stringency level)
5. DV = normalized confirmed cases; lm (IV = 7 constituent
factors of the Infectious Disease Vulnerability Index, A65abp,
stringency level)
6. DV = normalized confirmed cases; lm (Overall Score Normed,
A65abp, stringency level)
7. DV = normalized mortality; lm (IV = 7 constituent factors of
the Infectious Disease Vulnerability Index, A65abp, stringency
level)
8. DV = normalized mortality; lm (Overall Score Normed,
A65abp, stringency level).
Afterwards, the regression predictors were then assessed for
relative importance or assigning of weights using the relaimpo
package (25). All modeling was carried out in R.
3. RESULTS
Initially, we tested for various assumptions of linear regression
models. Using residual plots we checked for normality and
only minor deviations from normality were observed. None of
the predictor variables were considered to be dropped across
the four types of regression models; however, we did check
for multicollinearity using the measure variance inflation factor
(VIF). We realized the importance of this step in particular
when we considered the indexes in their split form, as it could
be expected that the predictors may possibly be correlated with
each other. VIF scores for all 9 predictor variables within the
Inform Index were high and beyond tolerance (>5) for both
confirmed cases and mortality. A65abp and the stringency level
were within an acceptable range (<5). When we used the
composite score of the Inform index alongside A65abp and the
stringency level, there were no issues whatsoever with respect
to multicollinearity. VIF scores for the predictors within the
Infectious Disease Vulnerability Index were beyond tolerance for
three of them (>5); namely economic domain, political domestic
and health care. A65abp and the stringency level were within an
acceptable range (<5). When we used the composite score of the
Infectious Disease Vulnerability index alongside A65abp and the
stringency level, there were no issues whatsoever with respect to
multicollinearity. As with the Inform Index, VIF scores mirrored
each other acrossmortality and confirmed cases for the Infectious
Disease Vulnerability Index.
Summary of our multiple linear regression models are
presented in the form of tables (see Tables 1–4). Tables 1, 2 tend
to illustrate that the Inform index had slightly higher predictive
power for the risk of COVID-19 confirmed cases. Particularly,
Table 1 shows that both A65abp and the composite value of the
Inform Index have significant predicting power for the risk of
COVID-19 confirmed cases. None of the predictor indicators
within the Inform index were significant for either of mortality or
confirmed cases. Their high multicollinearity also enforces us to
focus on the results from the regression model of the composite
Inform Index.
Tables 3, 4 highlight that the Infectious Disease Vulnerability
Index has lower predictive power than the Inform Index for
the risk of both confirmed cases and mortality for COVID-19.
Table 4 also highlights the weakness of the Infectious Disease
Vulnerability Index to explain COVID-19 mortality risk as none
of its constituent predictors or the index itself in its composite
form emerged as significant. Extending from our checks of
multicollinearity, we re-executed our linear regression model
using the split form of the Infectious Disease Vulnerability Index;
but dropped the three predictors having high VIF mentioned
earlier. In these new models (six each for normalized cases and
normalized mortality; six representing the six dates chosen in
our temporal analysis), there were no drastic changes in R2,
if anything it further deteriorated. Our R code and all output
generated is presented in a documented Supplementary File.
3.1. Discussion
In general the response variable variation or R2 was low for
both indexes and for both response variables, where most of the
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TABLE 1 | Regression Results for risk of confirmed cases as predicted by Inform Index in both split and composite form; where for p-values “***” represents p < 0.001
“**” represents p < 0.01 and “*” represents p < 0.05.
Split form Composite form
Date (all dates are 2020) R2 Significant p-values Top weights R2 Significant p-values Top weights
March 2 0.17 Stringency*** Stringency (0.64) 0.16 Stringency*** Stringency (0.84)
March 16 0.30 None
Social economics
vulnerability (0.14)






March 30 0.33 None
Institutional (0.17)






April 13 0.40 None
Institutional (0.16)






April 27 0.43 None
Institutional (0.16)






May 11 0.40 None
Infrastructure (0.13)




TABLE 2 | Regression Results for risk of mortality as predicted by Inform Index in both split and composite form; where for p-values “***” represents p < 0.001 “**”
represents p < 0.01 and “*” represents p < 0.05.
Split form Composite form
Date (all dates are 2020) R2 Significant p-values Top weights R2 Significant p-values Top weights
March 2 0.18 Stringency***
Stringency (0.63),
natural (0.15)
0.15 Stringency*** Stringency (0.89)
March 16 0.07 None A65abp (0.42) 0.06 A65abp**
Inform index (0.12),
A65abp (0.87)
March 30 0.16 A65abp*
A65abp (0.39),




April 13 0.28 A65abp**
A65abp (0.30),





April 27 0.31 A65abp**
A65abp (0.27),





May 11 0.32 A65abp**
A65abp (0.26),





indicators were not integral to the predictive power of the model.
The trend of both indexes was similar, as slight improvements in
predictive power of the model occurred over time. The inform
index did not have any significant constituent indicators within
its ranks.
Indicators from within the Infectious Disease Vulnerability
Index, such as public health domain were at different times
able to explain the variation in risk of COVID-19 confirmed
cases across the countries as shown by its significant predictive
power. The inform index in its composite form was a stronger
predictor for the risk of COVID-19 confirmed cases, whereas
the Infectious Disease Vulnerability Index was a significant
predictor of the risk of COVID-19 confirmed cases on May-
11. This clearly highlights that these indexes if anything,
the indexes were slightly more effective in explaining the
variation in confirmed cases on a global scale as compared
to mortality. The seemingly overall weak results highlight the
need of a customized and tailored composite index for risk
assessment related to COVID-19, particularly for mortality.
Prior literature also identifies the importance of considering
COVID-19 as very different from infectious diseases of the
past [such as SARS (26)]. Our identified indexes in this paper
were conceptualized in the pre-COVID era and hence are
finding it difficult to map and predict the risk of COVID-19.
Nevertheless, the ratio of elderly (A65abp) as a self-introduced
indicator was an important predictor for mortality risk as
evidenced by its weight and significance across the models.
The mortality risk associated with COVID-19 and the elderly
is widely recognized (27) and this association also emerged in
our results.
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TABLE 3 | Regression Results for risk of confirmed cases as predicted by Infectious Disease Vulnerability Index in both split and composite form; where for p-values “***”
represents p < 0.001 “**” represents p < 0.01 and “*” represents p < 0.05.
Split form Composite form
Date (all dates are 2020) R2 Significant p-values Top weights R2 Significant p-values Top weights
March 2 0.09 Stringency*
Stringency (0.38),





March 16 0.09 None







March 30 0.24 Public health domain**








April 13 0.29 Public health domain**


































TABLE 4 | Regression Results for risk of mortality as predicted by Infectious Disease Vulnerability Index in both split and composite form; where for p-values “***”
represents p < 0.001 “**” represents p < 0.01 and “*” represents p < 0.05.
Split form Composite form







0.14 Stringency*** Stringency (0.93)
March 16 0.06 None







March 30 0.10 A65abp*







April 13 0.19 A65abp*
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A key incremental novelty of our modeling approach to assess
COVID-19 risk was the introduction of a temporal independent
variable in the form of the stringency level of each country.
Stringency appeared to have predictive power till early March,
which is when there was most variation in stringency data.
Once the World Health Organization declared COVID-19 as
a pandemic around mid March (28), most countries scaled up
their stringency levels and it lost any association that it had in
modeling the mortality risk of COVID-19. This is exemplified
by the standard deviation of weighted stringency level for the
entire data set, which went from 11.3 on 02-03-2020 to 12.4 on
16-03-2020. This could also explain the drop or no change in
R2 for our date of 16-03-2020 (for 6 of the 8 scenarios). Prior
research has shown stronger outcomes in temporal assessments
of COVID-19 toward the start of the outbreak (29). Related
research (30) further informs us that controlling the spread
and risk of the COVID-19 virus relies more on personal and
individual measures, such as social distancing rather than only
emphasizing large scale governmental interventions.
4. CONCLUSION
In our analysis, we have attempted to use existing indexes to
assess prevailing COVID-19 spread and mortality risk. Our
results show that due to the inherent differences primarily related
to transmission between COVID-19 and other pandemics of the
past, future effort is to be dedicated to design customized indexes
once the impact of COVID-19 is understood. Further, the level
of stringency that a country had imposed was unable to explain
the variation across countries when it came to COVID-19 risk.
We discuss how this may have been a by-product of COVID-
19 being declared a pandemic around mid March 2020 when
most countries increased their stringency levels significantly. Our
analysis also confirmed the significant association between the
ratio of elderly (or above 65 years old) living in a population and
COVID-19 mortality risk as well as between the local prevailing
demographics and risk of COVID-19 spread. In addition, future
analysis of the like can also focus on regional assessments of
risk rather than global determinations which shrink countries to
single homogeneous index based indicators. Such analysis can
contribute toward a better understanding of public health policy
on a regional level, where there are more subtle nuances in the
available data. As our results have shown global indexes although
meant to discern countries at a world level; the complexities
of COVID-19 ultimately create challenges in mapping and
projecting its outlook on a global scale.
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